Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | AKN-028 |
Trade Name | |
Synonyms | BVT-II|AKN028 |
Drug Descriptions |
AKN-028 inhibits wild-type and mutant forms of FLT3 and KIT, potentially resulting in decreased tumor cell proliferation (PMID: 22864397). |
DrugClasses | FLT3 Inhibitor 69 KIT Inhibitor 57 |
CAS Registry Number | 1175017-90-9 |
NCIT ID | C101520 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
AKN-028 | AKN-028 | 0 | 0 |
AKN-028 + Cytarabine | AKN-028 Cytarabine | 0 | 0 |
AKN-028 + Daunorubicin | AKN-028 Daunorubicin | 0 | 0 |